The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: omalizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 175     Number of Pages: 9

DRUGNAME PT EventCount
Omalizumab Swelling 3 view events
Omalizumab Swelling face 3 view events
Omalizumab Abdominal wall abscess 2 view events
Omalizumab Abscess 2 view events
Omalizumab Anaphylactoid reaction 2 view events
Omalizumab Application site haemorrhage 2 view events
OMALIZUMAB Arrhythmia supraventricular 2 view events
Omalizumab Bronchospasm 2 view events
Omalizumab CD4 lymphocytes decreased 2 view events
Omalizumab CD8 lymphocytes decreased 2 view events
Omalizumab Conjunctivitis 2 view events
Omalizumab Croup infectious 2 view events
Omalizumab Cryptorchism 2 view events
Omalizumab Cutis laxa 2 view events
Omalizumab Dermatitis 2 view events
Omalizumab Dry skin 2 view events
OMALIZUMAB Endocarditis fibroplastica 2 view events
OMALIZUMAB Eosinophilic granulomatosis with polyangiitis 2 view events
Omalizumab Erythema 2 view events
Omalizumab Exposure during breast feeding 2 view events

Total Drug/Injury Combinations: 175     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)